Precancer of the prostate

Cancer Surveys

Volumn 32, Issue , 1998, Pages 149-179

  Busch, P C ^a   Egevad, L ^b   Haggman, M ^c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; RETINOBLASTOMA PROTEIN; UVOMORULIN;

CANCER GRADING; CANCER INVASION; FAMILIAL CANCER; GENETIC SUSCEPTIBILITY; HUMAN; METASTASIS; MULTIPLE CANCER; ONCOGENE; PLOIDY; PRECANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TUMOR SUPPRESSOR GENE; TWINS;

BIOPSY; CELL COMMUNICATION; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; MALE; PHENOTYPE; PRECANCEROUS CONDITIONS; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 0031681379     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (163)

1. Alcaraz A, Takahashi S, Brown JA et al (1994) Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Research 54 3998-4002
2. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast TH and van Dekken H (1995) Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes, Chromosomen and Cancer 12 241-250
3. Algaba F, Trias I, Lopez L, Rodriguez-Vailejo JM and Gonzales-Esteban J (1995) Neuroendocrine cells in peripheral prostatic zone age, prostatic intraepithelial neoplasia and latent cancer-related changes. European Urology 27 329-333
4. Allam CK, Bostwick DG, Hayes JA et al (1996) Interobserver variability in the diagnosis of high grade prostatic intraepithelial neoplasia and adenocarcinoma. Modern Pathology 6 742-751 (Supplement 71A)
5. Amin MB, Ro JY and Ayala AG (1993a) Putative precursor lesions of prostatic adenocarcinoma: fact or fiction? Modern Pathology 6 476-483
6. Amin MB, Schultz DS, Zarbo RJ, Kubus J and Shaheen C (1993b) Computerized static DNA ploidy analysis of prostatic intraepithelial neoplasia. Archives of Pathology and Laboratory Medicine 117 794-798
7. Bandyk MG, Zhao L, Troncosos P et al (1994) Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes, Chromosomes and Cancer 9 19-27
8. Baretton GB, Vogt T, Blasenbreu S and Lohrs U (1994) Comparison of DNA ploidy in prostatic intraepithelial neoplasia and invasive carcinoma of the prostate: an image cytometric study. Human Pathology 25 506-513
9. Bartels PH, Thompson D, Bartels HG, Montironi R, Scarpelli M and Hamilton PW (1995a) Machine vision based histometry of premalignant and malignant prostatic lesions. Pathology Research and Practice 191 935-944
10. Bartels PH, Thompson D, Montironi R, Hamilton PW and Scarpelli M (1995b) Diagnostic decision support for prostate lesions. Pathology Research and Practice 191 945-957
11. Bastacky SI, Wojno KJ, Walsh PC, Carmichael MJ and Epstein JI (1995) Pathological features of hereditary prostate cancer. Journal of Urology 153 987-992
12. Berges RR, Vukanovic J, Epstein JI et al (1995) Implication of cell kinetic changes during the progression of human prostate cancer. Clinical Cancer Research 1 473
13. Berner A, Danielsen HE, Pettersen EO, Fossa SD, Reith A and Nesland JM (1993) DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas. Analytical and Quantitative Cytology and Histology 15 247-252
14. Bigler SA, Deering RE and Brawer MK (1993) Comparison of microscopic vascularity in benign and malignant prostate tissue. Human Pathology 24 220-226
15. Bishop DT and Skolnick MH (1984) Genetic epidemiology of cancer in Utah genealogies: a prelude to the molecular genetics of common cancers. Journal of Cellular Physiology 3 (Supplement) 63-67
16. Boag AH and Young ID (1993) Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma. Modern Pathology 6 65-68
17. Boag AH and Young ID (1994) Increased expression of the 72-kd type IV collagenase in prostatic adenocarcinoma, Demonstration by immunohistochemistry and in situ hybridization. American Journal of Pathology 144 585-591
18. Bonkhoff H (1996) Role of the basal cells in the premalignant changes of the human prostate: a stemcell concept for the development of cancer. European Urology 30 201-205
19. Bonkhoff H, Stein U, Walter C and Remberger K (1995) Differential expression of the pS2 protein in the human prostate and prostate cancer association with premalignant changes and neuroendocrine differentiation. Human Pathology 26 824-828
20. Bookstein R, Rio P, Madreperla SA et al (1990) Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proceedings of the National Academy of Sciences of the USA 87 7762-7766
21. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F and Allred DC (1993) p53 is mutated in a subset of advanced-stage prostate cancers. Cancer Research 53 3369-3373
22. Bostwick DG (1988) Premalignant lesions of the prostate. Seminars in Diagnostic Pathology 5 240-253
23. Bostwick DG (1994) c-erbB-2 oncogene expression in prostatic intraepithelial neoplasia: mounting evidence for a precursor role. Journal of the National Cancer Institute 86 1108-1110
24. Bostwick DG (1995) High grade prostatic intraepithelial neoplasia: the most likely precursor of prostate cancer. Cancer 75 1823-1836
25. Bostwick DG and Brawer MK (1987) Prostatic intraepithelial neoplasia and early invasion in prostate cancer. Cancer 59 788-794
26. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT and Murphy GP (1992) The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 70 (Supplement 1) 291-301
27. Bostwick DG, Amin MB, Dundore P, Marsh W and Shultz DS (1993) Architectural patterns of high grade prostatic intraepithelial neoplasia (PIN). Human Pathology 42 298-310
28. Bostwick DG, Burke HB, Wheeler TM et al (1994a) The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials. Journal of Cellular Biochemistry 19 (Supplement) 283-289
29. Bostwick DG, Dousa MK, Crawford BG and Wollan PC (1994b) Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma. American Journal of Surgical Pathology 18 1240-1246
30. Bostwick DG, Quian J and Frankel K (1995) The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. Journal of Urology 154 1791-1794
31. Bova GS, Carter BS, Bussemakers MJG et al (1993) Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Research 53 3869-3873
32. Braun MM, Partin AW, Page WF and Walsh PC (1995) Prostate cancer concordance rates among World War II veteran twins suggest hereditary influences. Journal of Urology 153 (Supplement) 504A
33. Brawer MK, Nagle MD, Bigler SA, Lange PH and Sohlberg OE (1991) Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology 38 103-107
34. Brenner PC, Rettig WJ, Sanz-Moncasi MP et al (1995) TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49. Journal of Urology 153 1575-1579
35. Brooks JD, Bova GS and Isaacs WB (1995) Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinoma. Prostate 26 35-39
36. Brothman AR, Peehl DM, Patel AM and McNeal JE (1990) Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Research 50 3795-3803
37. Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM and Jenkins RB (1994) Chromosomal aneusomies detected by fluorescence in situ hybridization analysis in clinically localized prostate carcinoma. Journal of Urology 152 1157-1162
38. Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL and Smart CR (1982) Genetic epidemiology of prostate cancer in the Utah mormon genealogy. Cancer Surveys 1 48-49
39. Carter BS, Beaty TH, Steinberg GD, Childs B and Walsh PC (1990a) Mendelian inheritance of familial prostate cancer. Proceedings of the National Academy of Sciences of the USA 89 3367-3371
40. Carter BS, Epstein JI and Isaacs WB (1990b) Ras gene mutations in human prostate cancer. Cancer Research 50 6830-6832
41. Carter BS, Ewing CM, Ward WS et al (1990c) Allelic loss of chromosome 16q and 10q in human prostate cancer. Proceedings of the National Academy of Sciences of the USA 87 8751-8752
42. Carter BS, Bova GS, Beaty TH et al (1993a) Hereditary prostate cancer epidemiologic and clinical features. Journal of Urology 150 797-802
43. Carter HB, Piantadosi S and Isaacs JT (1993b) Clinical evidence for and implications of the multistep development of prostate cancer. Journal Urology 143 742-746
44. Cheng L, Shan A, Qian J et al (1998) Genetic heterogeneity in prostatic intraepithelial neoplasia and carcinoma: United States and Canadian Academy of Pathology annual meeting, Boston, Massachusetts, February 28-March 6 444 78A [Abstract]
45. Crissman JD, Sakr WA, Hussein ME et al (1993) DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate, Prostate 22 155-162
46. Davidson D, Bostwick DG, Qian J et al (1995) Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. Journal of Urology 154 1295-1299
47. de la Torre M, Hæggman M, Brændstedt S and Busch C (1993) Prostatic intraepithelial neoplasia (PIN) and invasive adenocarcinoma in total prostatectomy specimens. British Journal of Urology 72 207-213
48. Deschenes J and Weidner N (1990) Nucleolar organiser regions (NOR) in hyperplastic and neoplastic prostate disease. American Journal of Surgical Pathology 14 1148-1155
49. di Sant' Agnese PA (1992) Neuroendocrine differentiation in carcinoma of the prostate: diagnostic, prognostic and therapeutic implications. Cancer 70 254-268
50. Dong JT, Isaacs WB and Isaacs JT (1997) Molecular advances in prostate cancer. Current Opinion in Oncology 9 101-107
51. Drachenberg CB and Papadimitriou JC (1995) Aberrant pattern of lectin binding in low and high grade prostatic intraepithelial neoplasia. Cancer 75 2539-2544
52. Drago JR, Mostofi FK and Lee F (1989) Introductory remarks and workshop summary. Urology 34 (Supplement) 2-3
53. Effert PJ, McCoy RH, Walther PJ et al (1993) p53 gene alterations in human prostate carcinoma. Journal of Urology 150 257-261
54. Emmert-Buck MR, Vocke CD, Pozzatti RO et al (1995) Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia (PIN). Cancer Research 55 2959-2962
55. Epstein JI, Cho KR and Quinn BD (1990) Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of the prostate. Cancer 65 2321-2327
56. Epstein JI, Grignon DJ, Humphrey PA et al (1995) Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. American Journal of Surgical Pathology 19 873-886
57. Ewing CM, Ru N and Morton RA (1995) Chromosome 5 suppresses tumourigenicity of PC-3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function. Cancer Research 55 4813-4817
58. Ferguson J, Zincke H, Ellison E, Bergstrahi E and Bostwick DG (1994) Decrease of prostatic intraepithelial neoplasia (PIN) following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology 44 91-95
59. Giri DK, Wadhawa SN, Upadaya SN et al (1993) Expression of neu/her-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study. Prostate 23 329-336
60. Giroldi LA and Schalken JA (1993) Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metastasis Reviews 12 29-37
61. Giroldi LA, Bringuier PP and Schalken JA (1994-95) Defective E-cadherin function in urological cancers: clinical implications and molecular mechanisms. Invasion Metastasis 14 71-81
62. Goldgar DE, Easton DF, Cannon-Albright LA and Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. Journal of the National Cancer Institute 86 1600-1608
63. Gould VE, Doljanskaia V, Gooch G and Bostwick DG (1996) Immunolocalization of glycoprotein A-80 in prostatic carcinoma and prostatic intraepithelial neoplasia. Human Pathology 27 547-552
64. Gronberg H, Damber L and Damber JE (1994) Studies of genetic factors in prostate cancer in a twin population. Journal of Urology 152 1484-1489
65. Gronberg H, Damber L, Damber JE and Iselius L (1997) Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. American Journal of Epidemiology 146 552-557
66. Gunthert U, Stauder R, Mayer B, Terpe H-J, Finke L and Friedrichs K (1995) Are CD44 variant isoforms involved in human tumour progression? Cancer Surveys 24 19-42
67. Hamdy FC, Fadion EJ, Cottam D et al (1994) Matrix metalloproteinase expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. British Journal of Cancer 69 177-182
68. Hau J, Yang Y, McDaniel KM, Dalkin BL, Cress A and Nagle RB (1996) Differential expression of laminin 5 by human malignant and normal prostate. American Journal of Pathology 149 1341-1349
69. Hedrick L and Epstein JI (1989) Use of Keratin 903 as an adjunct in the diagnosis of prostate carcinoma. American Journal of Surgical Pathology 113 389-396
70. Hellstrom M, Haggman M, Brandstedt S et al (1993) Histopathological changes in andogen-deprived localized prostatic cancer: a study in total prostatectomy specimens. European Urology 24 461-465
71. Helpap B (1988) Observations on the number, size and location of nucleoli in hyperplastic and neoplastic prostatic disease. Histopathology 13 203-211
72. Helpap B (1995) Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate. Pathology Research and Practice 191 904-907
73. Helpap B and Riede C (1995) Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma. Pathology Research and Practice 191 381-390
74. Hsieh JT, Luo W, Song W et al (1995) Tumour suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Research 55 190-197
75. Humphrey PA and Swanson PE (1995) Immunoreactive p53 protein in high-grade prostatic intraepithelial neoplasia. Pathology Research and Practice 191 881-887
76. Ibrahim GK, Kerns BM, MacDonald JA et al (1993) Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. Journal of Urology 149 170-173
77. Iwamura M, Gershagen S, Lapets O et al (1995) Immunohistochemical localization of parathyroid hormone related protein in prostatic intraepithelial neoplasia. Human Pathology 26 797-801
78. Kanthoff PW, Febbo PG, Giovannucci E et al (1997) A polymorphism of the α-reductase gene and its association with prostate cancer: a case control analysis. Cancer Epidemiology, Biomarkers and Prevention 6 189-192
79. Kastendieck H (1980) Correlations between atypical primary hyperplasia and carcinoma of the prostate. Pathology Research and Practice 169 366-387
80. Kastendieck H and Helpap B (1989) Prostatic "dysplasia/atypical hyperplasia". Terminology, histopathology, pathobiology, and significance. Urology (Supplement) 34 28-42
81. Kleinerman DI, Troncoso P, Sue-Hwa L et al (1995) Consistent expression of an epithelial cell adhesion molecule (CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Research 55 1215-1220
82. Knox JD, Crew AE, Clark V et al (1994) Differential expression of extracellular matrix molecules and the alpha-6-integrins in the normal and neoplastic prostate. American Journal of Pathology 145 167-174
83. Kovi J, Mostofi FK, Heshmat MY and Enterline JP (1988) Large acinar atypical hyperplasia and carcinoma of the prostate. Cancer 61 555-561
84. Kubota Y, Shuin T, Fujinami K et al (1995) Tumor suppressor gene p53 mutations in human prostate cancer. Prostate 27 18-24
85. Kuczyk M, Serth J, Denil J, Hofner K, Allhoff E and Jonas U (1994) Cathepsin D expression and the possible role of lysosomal proteases as a prognostic factor in prostate cancer. Journal of Urology 151 [Abstract 286]
86. Kuhn EJ, Kurnot RA, Sesterhenn IA et al (1993) Expression of the c-erbB-2 (HER2/neu) oncoprotein in human prostatic carcinoma. Journal of Urology 150 1427-1433
87. Lalani E-N, Stubbs A and Stamp GWH (1997) Prostate cancer the interface between pathology and basic scientific research. Seminars in Cancer Biology 8 53-59
88. Langer JE, Rovner ES, Coleman BG et al (1996) Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. Journal of Urology 155 228-231
89. Langsten AA, Stanford JL, Wicklund KG, Thompson JD, Blazej RG and Ostrander EA (1996) Germ-line mutations in selected men with prostate cancer. American Journal of Human Genetics 58 885-888
90. Leav I, McNeal JE, Kwan PW, Komminoth P and Merk FB (1996) Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: an immunohistochemical and in situ hybridization study. Prostate 29 137-145
91. Lowe FC, Hillel K, Thiel R, Chen R and Luderer AA (1996) Follow-up of high grade prostatic intraepithelial neoplasia: clinical implications. Journal of Urology 155 [Abstract 605]
92. McIndoe RA, Stanford JL, Gibbs M et al (1997) Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. American Journal of Human Genetics 61 347-353
93. McNeal JE and Bostwick DG (1986) Intraductal dysplasia: a premalignant lesion of the prostate. Human Pathology 17 64-71
94. McNeal JE, Leav I, Alroy J and Skutellsky E (1988a) Differential lectin staining of the central and peripheral zones of the prostate and alterations in dysplasia. American Journal of Clinical Pathology 89 41-48
95. McNeal JE, Alroy J, Leav I, Redwine EA, Freiha FS and Stamey TA (1988b) Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. American Journal of Clinical Pathology 90 23-32
96. McNeal JE, Villers A, Redwine E A, Freiha FS and Stamey TA (1991) Microcarcinoma of the prostate: its association with duct-acinar dysplasia. Human Pathology 22 644-652
97. Macoska JA, Micale MA, Sakr WA, Benson PD and Wolman SR (1993) Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes, Chromosomes and Cancer 8 88-97
98. Macoska JA, Trybus TM, Sakr WA et al (1994) Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Research 54 3824-3830
99. Macoska JA, Trybus TM, Benson PD et al (1995) Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Research 55 5390-5395
100. Makar R, Mason A, Kittelson JM, Bowden GT, Cress AE and Nagle RB (1994) Immunohistochemical analysis of cathepsin D in prostate carcinoma. Modem Pathology 7 747-751
101. Maygarden SJ (1994) Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia. Pathology Annual 29 303-320
102. Maygarden SJ, Strom S and Ware JL (1992) Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Archives of Pathology and Laboratory Medicine 116 269-273
103. Meilon K, Thompson S, Charlton RG et al (1992) p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. Journal of Urology 147 496-499
104. Miller A and Seljelid R (1971) Cellular dysplasia in the prostate. Scandinavian Journal of Urology and Nephrology 5 17-21
105. Min KW, Jin J-K, Blank J and Hemstreet G (1990) AGNOR in the human prostatic gland. American Journal of Clinical Pathology 95 508-512
106. Mirchandani, D, Zheng J, Miller GJ et al (1995) Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. American Journal of Pathology 47 92-101
107. Montironi R, Scarpelli M, Sisti S, Braccisch A and Mariuzzi GM (1990) Quantitative analysis of prostatic intra-epithelial neoplasia on tissue sections. Analytical and Quantitative Cytology and Histology 12 366-072
108. Montironi RM, Scarpelli M, Galuzzi CM and Diamanti L (1992) Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN). Journal of Cellular Biochemistry Supplement 16H 47-53
109. Montironi R, Magi Gailuzzi C, Diamanti L et al (1993a) Prostatic intra-epithelial neoplasia: qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections. Pathology Research and Practice 189 542-548
110. Montironi R, Magi-Galluzzi C, Diamanti L et al (1993b) Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen (PCNA) in epithelial, endothelial and stromal nuclei. Virchows Archiv A, Pathological Anatomy and Histopathology 422 185-192
111. Montironi R, Magi Galiuzzi C, Scarpelli M, Giannulis I and Diamanti L (1993c) Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia. Virchows Archiv A, Pathological Anatomy and Histopathology 423 351-357
112. Montironi R, Bartels PH, Thompson D, Bartels HG, Scarpelli M and Hamilton PW (1994a) Prostatic intraepithelial neoplasia: development of a Bayesian Belief Network for diagnosis and grading. Analytical and Quantitative Cytology and Histology 16 101-112
113. Montironi R, Magi-Gailuzzi C, Muzzonigro G, Prete E, Polito M and Fabris G (1994b) Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. Journal of Clinical Pathology 47 906-913
114. Montironi R, Bartels PH, Thompson D, Bartels HG, Scarpelli M and Hamilton PW (1995a) Prostatic intraepithelial neoplasia (PIN): performance of Bayesian Belief Network for diagnosis and grading. Journal of Pathology 177 153-162
115. Montironi R, Bartels PH, Thompson D, Bartels HG and Scarpelli M (1995b) Prostatic intraepithelial neoplasia: quantitation of the basal cell layer with machine vision system. Pathology Research and Practice 191 917-923
116. Montone KT and Tomaszewski JE (1993) In situ hybridization for epidermal growth factor receptor (EGFR) external domain transcripts in prostatic adenocarcinoma. Journal of Clinical and Laboratory Analysis 7 188-195
117. Morton RA, Ewing CM, Nagafuchi A, Tsukita S and Isaacs WB (1993) Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Research 53 3585-3590
118. Mostofi FK (1984) Precancerous lesions of the prostate, In Carter RL (ed). Precancerous States, pp 304-316, Oxford University Press, New York
119. Mostofi FK, Sesterhenn IA and Davis CJ (1989) Malignant change in hyperplastic prostate glands: the AFIP experience. Urology 34 49-51
120. Murant SJ, Handley J, Stower M, Reid N, Cussenot O and Maitland NJ (1997) Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. European Journal of Cancer 33 263-271
121. Myers RB and Grizzle WE (1997) Changes in biomarker expression in the development of prostatic adenocarcinoma. Biotechnology and Histochemistry 72 86-95
122. Myers RB, Kudlow JE and Grizzle WE (1993) Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Modern Pathology 6 733-737
123. Myers RB, Oelschlager D, Srivastava S and Grizzle WE (1994a) Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas. Prostate 25 243-248
124. Myers RB, Srivastava S, Oelschlager DK and Grizzle WE (1994b) Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Journal of the National Cancer Institute 86 1140-1145
125. Myers RB, Lampejo O, Herrera GA et al (1995) TGF-alpha expression is a relatively late event in the progression of prostatic adenocarcinoma. Journal of Urology Pathology 3 195-204
126. Nagle RB, Brawer MK, Kittelson J and Clark V (1991) Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. American Journal of Pathology 138 119-128
127. Nagle RB, Hao J, Know JD, Dalkin BL, Clark V and Cress AE (1995) Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. American Journal of Pathology 146 1498-1507
128. O'Malley F, Grignon D, Keeney M, Kerkvliet N and McLean C (1991) DNA flow-cytometric studies of prostatic intraepithelial neoplasia. Modern Pathology 4 [Abstract 50]
129. Oyasu R, Bahnson RR, Nowels K and Garnett JE (1986) Cytological atypia in the prostate gland: frequency, distribution and possible relevance to carcinoma. Journal of Urology 135 959-962
130. Perez M, Regan T, Pflug B, Lynch J, and Djakiew D 1997. Loss of low affinity nerve growth factor receptor during malignant transformation of the human prostate. Prostate 30 274-279
131. Petein M, Michel P, Van Velthoven R et al (1991) Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis. American Journal of Clinical Pathology 96 628-634
132. Qian J and Bostwick DG (1995) The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: Relationship with carcinoma in radical prostatectomy specimens. Pathology Research and Practice 191 860-867
133. Qian J, Bostwick DG, Takahashi S et al (1995) Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Research 55 5408-5414
134. Qian J, Wollan P and Bostwick DG (1997) Extent and multicentricity of high grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Human Pathology 28 143-148
135. Quinn BD, Cho KR and Epstein JI (1990) Relationship of severe dysplasia to stage B adenocarcinoma of prostate. Cancer 65 2328-2337
136. Robertson CN, Roberson KM, Herzberg AJ, Kerns BJM, Dodges RK and Pauison DF (1994) Differential immunoreactivity of transforming growth factor alpha in benign, dysplastic and malignant prostatic tissues. Surgical Oncology 3 237-242
137. Sakr WA, Haas GP, Drozdowicz SM et al (1992) Nuclear DNA content of prostatic carcinoma and intraepithelial neoplasia (PIN) in young males. An image analysis study. Modern Pathology 5 [Abstract 58]
138. Sakr WA, Haas GP, Cassin BF, Pontes JE and Crissman JD (1993a) The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. Journal of Urology 150 379-385
139. Sakr WA, Sarkar FH, Sreepathi P, Drozdowicz S and Crissman JD (1993b) Measurement of cel lular proliferation in human prostate by AGNOR, PCNA and SPF. Prostate 22 147-154
140. Sakr WA, Grignon DJ, Crissman JD et al (1994) High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases. In Vivo 8 439-443
141. Salem CE, Tomasic NA, Elmajian DA et al (1997) p53 protein and gene alterations in pathological stage C prostate carcinoma. Journal of Urology 158 510-514
142. Sarkar FH, Sakr W, Li YW et al (1992) Analysis of retinoblastoma (RB) gene deletion in human prostatic carcinomas. Prostate 21 145-152
143. Sesterhenn IA, Becker RL, Avallone FA, Mostofi FK, Lin TE and Davis CJ (1991) Image analysis of nucleoli and nucleolar organiser regions in prostatic hyperplasia, intraepithelial neoplasia, and prostatic carcinoma. Journal of Urogenital Pathology 1 61-74
144. Shah IA, Schlageter MO, Stinnett P and Lechago J (1991) Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. Modern Pathology 4 220-224
145. Sheng S, Carey J, Seftor EA et al (1996) Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proceedings of the National Academy of Sciences of the USA 93 11669-11674
146. Sikes RA and Chung LWK (1992) Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Cancer Research 52 3174-3178
147. Sinha AA, Wilson LU, Gleason DF, Reddy PK, Sameni M and Sloane BF (1995) Immunohistochemical localization of cathepsin B in neoplastic human prostate. Prostate 26 171-178
148. Smith JR, Freije D, Carpten JD et al (1996) Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274 1371-1374
149. Stattin P, Damber JE, Karlberg L, Nordgren H and Bergh A (1996) Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survival. Urological Research 24 257-264
150. Stearns ME and Stearns M (1993) Autocrine factors, type IV collagenase secretion and prostatic cancer cell invasion. Cancer Metastasis Reviews 12 39-52
151. Takahashi S, Qian J, Brown JA et al (1994) Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization. Cancer Research 54 3574-3579
152. Tennant MK, Trasher JB, Twomey PA, Birnbaum RS, and Plymate SR (1996) Insulin-like growth factor-binding protein (IGFB)-4, -5 and 6 in the benign and malignant human prostate: IGFB-5 messenger ribonucleic acid localization differs from IGFB-5 protein localization. Journal of Clinical Endocrinology and Metabolism 81 3783-3792
153. Troncoso P, Babaian RJ, Ro JY, Grignon DJ, Eschenbach AC and Ayala AG (1989) Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. Urology 34 (Supplement) 52-56
154. Turkeri LN, Sakr WA, Wykes SM, Grignon DJ, Pontes JE and Macoska JA (1994) Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant and malignant prostate tissue. Prostate 25 199-205
155. Ware JL (1993) Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Reviews 12 287-301
156. Waters DJ and Bostwick DG (1997) The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression. Anticancer Research 17 1467-1470
157. Weinberg DS and Weidner N (1993) Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant carcinoma evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma. Archives of Pathology and Laboratory Medicine 117 1132-1137
158. Weinstein MH and Epstein JI (1993) Significance of high grade prostatic intraepithelial neoplasia on needle biopsy. Human Pathology 24 624-629
159. Woolf CM (1960) An investigation of the familial aspects of carcinoma of the prostate. Cancer 13 739
160. Zenkiusen JC, Thompson JC, Troncoso P, Kagan J and Cont CJ (1994) Loss of heterozygosity in human primary prostatic carcinomas: a possible tumor suppressor gene at 7q31.1. Cancer Research 54 6870-6873
161. Zhau HE, Wan DS, Zhou J et al (1992) Expression of c-erbB-2/neu proto-oncogene in human prostatic cancer, tissues and cell lines. Molecular Carcinogenesis 5 320-327
162. Zitzeisberger H, Szves S, Weier HU et al (1994) Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin embedded tissue sections with centromere-specific DNA probes. Journal of Pathology 172 325-335
163. Zou Z, Anisowicz A, Hendrix MJC et al (1994) Maspin, a serpin with tumour suppressing activity in human mammary epithelial cells. Science 263 526-529